What type of research is a nurse conducting if they are using a quasi-experimental design?

Choice A rationale
Documenting the application of the medication is important for maintaining accurate medical records, but it is not the priority action when a patient is receiving a new medication.
Choice B rationale
Informing the patient about potential side effects is the correct answer. This action ensures that the patient is aware of what to expect and can report any adverse reactions promptly, which is crucial for their safety.
Choice C rationale
Checking the patient’s vital signs frequently is important, but it is not the priority action when a patient is receiving a new medication. The priority is to inform the patient about potential side effects.
Choice D rationale
Leaving the patient alone to rest is not appropriate when a patient is receiving a new medication. The nurse should monitor the patient and inform them about potential side effects.

Choice A rationale
Ignoring the comment and documenting “No Known Allergies” (NKA) is incorrect because it disregards the client’s report of an allergy. This action could lead to potential harm if the client is indeed allergic to codeine.
Choice B rationale
Asking the client why they think it is an allergy is not the best response. It may come across as dismissive and does not provide the nurse with specific information about the client’s allergic reaction.
Choice C rationale
Telling the client not to worry and that they will be okay if they take codeine with food is incorrect. This response is dismissive of the client’s concern and does not address the potential for an allergic reaction.
Choice D rationale
Asking the client what symptoms they experience with codeine is the best response. It allows the nurse to gather specific information about the client’s allergic reaction, which is crucial for safe medication administration.